* Somalogic Inc SLGC.OQ reported a quarterly adjusted loss
of 26
cents per share for the quarter ended in December. The mean
expectation of four analysts for the quarter was for a loss
of 21 cents per share.
* Revenue fell 18.1% to $18.83 million from a year ago;
analysts
expected $16.55 million.
* Somalogic Inc's reported EPS for the quarter was a loss
of 26
cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Somalogic Inc shares had fallen by 6.0% this quarter.
* The company reported a quarterly loss of $49.25 million.
* Wall Street's median 12-month price target for Somalogic
Inc is
$7.00
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
March 28 at 09:54 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 -0.21 -0.26 Missed
Sep. 30 2022 -0.20 -0.18 Beat
Jun. 30 2022 -0.18 -0.13 Beat
Mar. 31 2022 -0.16 -0.02 Beat